Ceftazidime-avibactam versus meropenem for the treatment of nosocomial pneumonia

Andre C Kalil, Michael Klompas

Research output: Contribution to journalComment/debate

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)229-231
Number of pages3
JournalThe Lancet Infectious Diseases
Volume18
Issue number3
DOIs
StatePublished - Mar 2018

Fingerprint

meropenem
Pneumonia
ceftazidime drug combination avibactam

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Ceftazidime-avibactam versus meropenem for the treatment of nosocomial pneumonia. / Kalil, Andre C; Klompas, Michael.

In: The Lancet Infectious Diseases, Vol. 18, No. 3, 03.2018, p. 229-231.

Research output: Contribution to journalComment/debate

@article{b3c006dc7f71421490bc144530650f29,
title = "Ceftazidime-avibactam versus meropenem for the treatment of nosocomial pneumonia",
author = "Kalil, {Andre C} and Michael Klompas",
year = "2018",
month = "3",
doi = "10.1016/S1473-3099(17)30748-X",
language = "English (US)",
volume = "18",
pages = "229--231",
journal = "The Lancet Infectious Diseases",
issn = "1473-3099",
publisher = "Lancet Publishing Group",
number = "3",

}

TY - JOUR

T1 - Ceftazidime-avibactam versus meropenem for the treatment of nosocomial pneumonia

AU - Kalil, Andre C

AU - Klompas, Michael

PY - 2018/3

Y1 - 2018/3

UR - http://www.scopus.com/inward/record.url?scp=85039442786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039442786&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(17)30748-X

DO - 10.1016/S1473-3099(17)30748-X

M3 - Comment/debate

C2 - 29254861

AN - SCOPUS:85039442786

VL - 18

SP - 229

EP - 231

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

SN - 1473-3099

IS - 3

ER -